THE TGA has approved the supply of an alternative product for glyceryl trinitrate (GTN) tablets (Anginine and Lycinate), namely Nitrostat supplied by Pfizer in the US.
The tabs come in 300 mcg and 600mcg forms, and are designed for sublingual disintegration, with the approval following a safety advisory issued last year (PD 29 Jul) about a new GTN formulation being slower to dissolve - tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Feb 17
